LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 1 | B15 | 72 | hr | 1311 | 1358 | 5128 | 0.2648 | 0.0178 |
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 2 | B15 | 72 | hr | 1311 | 1585 | 5100 | 0.3108 | 0.1014 |
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 3 | B15 | 72 | hr | 1311 | 1379 | 5010 | 0.2752 | 0.0262 |
MDA-MB-231 | Tozasertib | 3.33 | uM | LJP5 | 1 | B14 | 72 | hr | 1311 | 1452 | 5128 | 0.2831 | 0.0530 |
MDA-MB-231 | Tozasertib | 3.33 | uM | LJP5 | 2 | B14 | 72 | hr | 1311 | 1652 | 5100 | 0.3239 | 0.1250 |
MDA-MB-231 | Tozasertib | 3.33 | uM | LJP5 | 3 | B14 | 72 | hr | 1311 | 1439 | 5010 | 0.2872 | 0.0491 |
MDA-MB-231 | Tozasertib | 10 | uM | LJP5 | 1 | B13 | 72 | hr | 1311 | 1394 | 5128 | 0.2718 | 0.0314 |
MDA-MB-231 | Tozasertib | 10 | uM | LJP5 | 2 | B13 | 72 | hr | 1311 | 1531 | 5100 | 0.3002 | 0.0821 |
MDA-MB-231 | Tozasertib | 10 | uM | LJP5 | 3 | B13 | 72 | hr | 1311 | 1332 | 5010 | 0.2658 | 0.0080 |
MDA-MB-231 | Imatinib | 0.04 | uM | LJP6 | 1 | N18 | 72 | hr | 1311 | 4912 | 4870 | 1.0086 | 1.0090 |
MDA-MB-231 | Imatinib | 0.04 | uM | LJP6 | 2 | N18 | 72 | hr | 1311 | 4507 | 4961 | 0.9084 | 0.9023 |
MDA-MB-231 | Imatinib | 0.04 | uM | LJP6 | 3 | N18 | 72 | hr | 1311 | 5140 | 4973 | 1.0334 | 1.0345 |
MDA-MB-231 | Imatinib | 0.12 | uM | LJP6 | 1 | N17 | 72 | hr | 1311 | 4924 | 4870 | 1.0110 | 1.0116 |
MDA-MB-231 | Imatinib | 0.12 | uM | LJP6 | 2 | N17 | 72 | hr | 1311 | 4425 | 4961 | 0.8918 | 0.8842 |
MDA-MB-231 | Imatinib | 0.12 | uM | LJP6 | 3 | N17 | 72 | hr | 1311 | 5182 | 4973 | 1.0419 | 1.0431 |
MDA-MB-231 | Imatinib | 0.37 | uM | LJP6 | 1 | N16 | 72 | hr | 1311 | 5125 | 4870 | 1.0523 | 1.0546 |
MDA-MB-231 | Imatinib | 0.37 | uM | LJP6 | 2 | N16 | 72 | hr | 1311 | 4593 | 4961 | 0.9257 | 0.9212 |
MDA-MB-231 | Imatinib | 0.37 | uM | LJP6 | 3 | N16 | 72 | hr | 1311 | 4974 | 4973 | 1.0000 | 1.0000 |
MDA-MB-231 | Imatinib | 1.11 | uM | LJP6 | 1 | N15 | 72 | hr | 1311 | 4967 | 4870 | 1.0199 | 1.0209 |
MDA-MB-231 | Imatinib | 1.11 | uM | LJP6 | 2 | N15 | 72 | hr | 1311 | 4450 | 4961 | 0.8969 | 0.8898 |
MDA-MB-231 | Imatinib | 1.11 | uM | LJP6 | 3 | N15 | 72 | hr | 1311 | 5086 | 4973 | 1.0226 | 1.0233 |
MDA-MB-231 | Imatinib | 3.33 | uM | LJP6 | 1 | N14 | 72 | hr | 1311 | 5013 | 4870 | 1.0293 | 1.0308 |
MDA-MB-231 | Imatinib | 3.33 | uM | LJP6 | 2 | N14 | 72 | hr | 1311 | 4719 | 4961 | 0.9511 | 0.9484 |
MDA-MB-231 | Imatinib | 3.33 | uM | LJP6 | 3 | N14 | 72 | hr | 1311 | 5409 | 4973 | 1.0875 | 1.0892 |
MDA-MB-231 | Imatinib | 10 | uM | LJP6 | 1 | N13 | 72 | hr | 1311 | 4574 | 4870 | 0.9392 | 0.9348 |